tirzepatide direct Compounded Direct Meds GLP-1 2026: Claims

Insulin resistance in chronic heart failure

Avoid sugary drinks such as soda, sports drinks, juices and sweet tea

Early and protective microglial activation in Alzheimers disease: a prospective study using 18 F-DPA-714 PET imaging

Participants were selected and screened by the investigators and randomized across 65 sites in Brazil, the China region (consisting of mainland China, Taiwan and Hong Kong), the Republic of Korea, South Africa and Ukraine in a 2:2:1:1 manner to receive one of: semaglutide 0.5 mg and sitagliptin placebo, semaglutide 1.0 mg and sitagliptin placebo, sitagliptin 100 mg and semaglutide placebo (0.5 mg), or sitagliptin 100 mg and semaglutide placebo (1.0 mg)